| Health / Medical Topics |
HM89 Regimen
A regimen administered in four phases that is used for the treatment of disseminated, childhood, anaplastic large cell lymphoma (ALCL). The 4 phases in the regimen include: COP (cyclophosphamide, vincristine and prednisone); COPADM (cyclophosphamide, vincristine, prednisone, doxorubicin, and methotrexate); VEM (etoposide, cyclophosphamide and methotrexate); and VAD (vincristine and doxorubicin). (NCI Thesaurus)
YOU MAY ALSO LIKE
Human HLTF wild-type allele is located within 3q25.1-q26.1 and is approximately 56 kb in length. This allele encodes helicase-like transcription factor protein,…
This gene is involved in chromatin remodeling and regulation of transcription.
A rare inherited disorder that increases the risk of developing benign (not cancer) tumors of the skin and the uterus (leiomyomas) and…
A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein…
In transcription regulators of cell cycle control, cell determination, and cell differentiation, the conserved HLH (Helix-Loop-Helix) Domain of 40-50 amino acids forms…
A rare disorder in which histiocytes and lymphocytes (types of white blood cells) build up in organs including the skin, spleen, and…
